| Literature DB >> 19418475 |
Carl-Fredrik Mandenius1, Klaus Graumann, Torsten W Schultz, Andreas Premstaller, Ing-Marie Olsson, Emma Petiot, Christoph Clemens, Mats Welin.
Abstract
The following article is a report from a workshop on Quality-by-Design (QbD) held at the 7th European Symposium on Biochemical Engineering Science (7 September 2008, Faro, Portugal).The aim of the workshop was to provide an update on the present status of using QbD in biotechnology-related applications in the pharmaceutical industry. The report summarizes the essential parts of the presentations and covers the industrial, academic, and regulatory aspects of QbD. It concludes with recommendations for further work and development.Mesh:
Year: 2009 PMID: 19418475 DOI: 10.1002/biot.200800333
Source DB: PubMed Journal: Biotechnol J ISSN: 1860-6768 Impact factor: 4.677